Table 2 Transcription factors significantly enriched for predicted deleterious de novo variants

From: Meta-analysis reveals transcription factors and DNA binding domain variants associated with congenital heart defect and orofacial cleft

Gene

LOEUF

de novo variants

Inherited variants

de novo and case/control q value

de novo only q value

pLoF

MisA

MisB

Case pLoF

Control pLoF

Congenital heart defect

GATA6

0.174

3

2

0

0

0

2.5×10−5

3.5×10−6

KMT2A

0.065

5

0

1

0

0

3.2×10−4

5.0×10−5

ADNP

0.123

4

0

0

0

1

5.8×10−4

3.1×10−4

KDM5Ba

0.572

4

0

0

2

4

0.012159

5.2×10−4

NR2F2

0.217

2

1

0

0

0

0.014122

0.002103

FOXP1a

0.175

2

1

0

0

0

0.029404

0.003100

TBX5

0.135

1

1

0

1

0

0.031389

0.053298

GATA4

0.527

2

0

0

2

1

0.040077

0.050796

TCF12

0.372

1

1

0

2

1

0.051542

0.068473

ZEB2

0.107

1

1

0

1

0

0.058741

0.131609

KLF2a

0.710

1

1

0

0

0

0.204573

0.032261

SMAD4

0.222

0

2

0

0

0

0.209108

0.035057

MEIS2a

0.184

2

0

0

0

0

0.271015

0.055872

CTCFa

0.148

0

2

0

0

0

0.278293

0.058374

Orofacial cleft

SATB2

0.091

7

5

0

0

0

3.86×10−14

5.77×10−15

TFAP2A

0.261

2

3

0

1

0

2.84×10−6

7.70×10−6

CTCF

0.148

0

3

0

0

0

0.011737

0.001484

IRF6

0.132

1

0

3

1

0

0.002951

0.007637

TP63

0.267

1

1

0

3

0

0.003631

0.072430

SOX5b

0.188

1

1

0

1

0

0.018728

0.058691

ADNPb

0.123

2

0

0

0

1

0.092444

0.088307

GRHL2b

0.270

2

0

0

0

0

0.328840

0.076571

  1. LOEUF loss-of-function observed/expected upper bound fraction36, pLoF predicted loss-of-function, MisA PrimateAI > 0.9, MisB PrimateAI 0.75-0.9.
  2. Q values less than 0.1 are bolded.
  3. aNovel candidate CHD genes.
  4. bNovel candidate OFC genes.